Evidence map›Paper›PMID 32814095›Full record

ReviewTrends in cardiovascular medicine2020

COVID-19 infection and cardiac arrhythmias.

Antonis S Manolis, Antonis A Manolis, Theodora A Manolis, Evdoxia J Apostolopoulos, Despoina Papatheou, Helen Melita

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Trends in cardiovascular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06001879 (Protocol Title), which is not on this map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06001879 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Protocol Title : Development, Validation, and Evaluation of the Effectiveness of Simulation in Basic Life Support Training (SBLST) on Newly Employed Nurses in Governmental Jordanian Hospitals.

TypeinterventionalSponsoryousef Shukry Mohammad Abu-WardehRan2022 to 2024Enrolled102ConditionsHealthy Nurses, Educational ActivitiesArmsSimulation in basic life support training (SBLST), standard treatment by using an AHA-BLS 2020 brochure
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Pathogenic mechanisms of cardiovascular damage in COVID-19.Molecular medicine (Cambridge, Mass.) · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. COVID-19 and Atrial Fibrillation: Predicting to Prevent.Arquivos brasileiros de cardiologia · 2024
    Article
  17. The Potential Mechanisms of Arrhythmia in Coronavirus disease-2019.International journal of medical sciences · 2024
    Review
  18. Review
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Antonis S ManolisFirst Department of Cardiology, Athens University School of Medicine, Athens, Greece. Electronic address: asm@otenet.gr.
Antonis A ManolisPatras University School of Medicine, Patras, Greece.
Theodora A ManolisRed Cross Hospital, Athens, Greece.
Evdoxia J ApostolopoulosCanterbury Christ Church University, Canterbury, UK.
Despoina PapatheouOnassis Cardiac Surgery Center, Athens, Greece.
Helen MelitaOnassis Cardiac Surgery Center, Athens, Greece.
Onassis Cardiac Surgery Center · GRUniversity of Patras · GRCanterbury Christ Church University · GBHellenic Red Cross · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the coronavirus 2019 (COVID-19) pandemic marches unrelentingly, more patients with cardiac arrhythmias are emerging due to the effects of the virus on the respiratory and cardiovascular (CV) systems and the systemic inflammation that it incurs, and also as a result of the proarrhythmic effects of COVID-19 pharmacotherapies and other drug interactions and the associated autonomic imbalance that enhance arrhythmogenicity. The most worrisome of all arrhythmogenic mechanisms is the QT prolonging effect of various anti-COVID pharmacotherapies that can lead to polymorphic ventricular tachycardia in the form of torsade des pointes and sudden cardiac death. It is therefore imperative to monitor the QT interval during treatment; however, conventional approaches to such monitoring increase the transmission risk for the staff and strain the health system. Hence, there is dire need for contactless monitoring and telemetry for inpatients, especially those admitted to the intensive care unit, as well as for outpatients needing continued management. In this context, recent technological advances have ushered in a new era in implementing digital health monitoring tools that circumvent these obstacles. All these issues are herein discussed and a large body of recent relevant data are reviewed.

Indexed as

COVID-19 Drug TreatmentAntiviral AgentsArrhythmias, CardiacCardiotoxicityCOVID-19Drug InteractionsHeart Conduction SystemHeart RateHost-Pathogen InteractionsHumansPrognosisRisk AssessmentRisk FactorsSARS-CoV-2Antiviral AgentsAtrial fibrillationCardiac arrhythmiasCOVID-19Long QT syndromeMyocarditisSARS-CoV-2Sudden cardiac deathTorsade des pointesVentricular fibrillationVentricular tachycardia

Identifiers

PMID32814095
PMCPMC7429078
OpenAlexW3048747544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.